Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research ...

Global study evaluates novel KRAS G12D-targeted protein degrader against docetaxel in previously treated advanced NSCLC, ...

Verato ® announced a partnership with Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and ...

First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and TANDEM trials demonstrating significant LDL-C reductions ...

Strategic collaboration combines Sanyou Bio’s AI-powered antibody discovery and dual-target, dual-payload ADC capabilities ...

The most consequential APAC biopharma deal of 2026 is Sun Pharma's all-cash agreement to buy Organon, which Sun describes as ...

Gibco CHO-K1 portfolio delivers up to 73% higher protein titres and 202% higher peak viable cell density, supporting faster ...

Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic ...

New 9,940-square-metre Vision Centre in Southampton brings R&D, clinical expertise, AI-enabled technologies and pilot ...

With embedded AI agents and clinical decision support built in, the context-aware EHR is expected to help care teams navigate ...

Turbine’s vLab platform will deploy computational Virtual Assays across Daiichi Sankyo’s proprietary ADC programmes to ...

Figure 1. The 2026 approvals timeline: one dot per new active substance, by month and authority. Solid dots are ...